» Articles » PMID: 11742488

Tallness and Overweight During Childhood Have Opposing Effects on Breast Cancer Risk

Overview
Journal Br J Cancer
Specialty Oncology
Date 2001 Dec 18
PMID 11742488
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Using birth and school health records we studied how weight and height during childhood affect breast cancer risk among 3447 women born during 1924-33 at the University Hospital of Helsinki, Finland. Through linkages with the National Hospital Discharge Registry and the Cause of Death Registry we identified 177 women who during 1971-1995 had been admitted to hospital with breast cancer, of whom 49 had died from the disease. Of these, 135 (76%) were aged 50 years or more at the time of diagnosis, and therefore likely to have been post-menopausal. Hazard ratios for breast cancer rose with increasing weight and length at birth, though neither trend was statistically significant. At each age, from 7 to 15 years, the girls who later developed breast cancer were on average taller and had lower body mass than the other girls. Unadjusted hazard ratios rose across the range of height (P = 0.01 at age 7 years) and fell across the range of body mass index (P = 0.009 at age 7 years). In a simultaneous analysis the hazard ratio for breast cancer was 1.27 (95% CI 0.97-1.78, P = 0.08) for every kilogram increase in birth weight and 1.21 (95% CI 1.06-1.38, P = 0.004) for every kg/m(2) decrease in body mass index at 7. Our findings indicate that tallness in childhood is associated with increased risk of developing breast cancer. One possible explanation is persisting high plasma concentrations of insulin-like growth factors in tall women. In contrast, we found that being overweight in childhood reduces breast cancer risk. The increased adipose tissue-derived oestrogen levels in overweight children could induce early breast differentiation and eliminate some targets for malignant transformation.

Citing Articles

The Prospective Association between Early Life Growth and Breast Density in Young Adult Women.

Lloyd R, Pirikahu S, Walter J, Cadby G, Warrington N, Perera D Cancers (Basel). 2024; 16(13).

PMID: 39001479 PMC: 11240569. DOI: 10.3390/cancers16132418.


Dose response relationship between breast cancer and somatotypes during childhood: a systematic review and meta-analysis.

Dou Y, Chen B, Yu X, Xin Q, Ma D Br J Cancer. 2023; 129(9):1432-1441.

PMID: 37550527 PMC: 10628206. DOI: 10.1038/s41416-023-02376-x.


Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.

Kast K, John E, Hopper J, Andrieu N, Nogues C, Mouret-Fourme E Breast Cancer Res. 2023; 25(1):72.

PMID: 37340476 PMC: 10280955. DOI: 10.1186/s13058-023-01673-w.


Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes.

Pedersen D, Jensen B, Tjonneland A, Andersen Z, Mellemkjaer L, Bjerregaard L Breast Cancer Res. 2022; 24(1):77.

PMID: 36369105 PMC: 9652814. DOI: 10.1186/s13058-022-01578-0.


The timing of adiposity and changes in the life course on the risk of cancer.

Fang Z, Giovannucci E Cancer Metastasis Rev. 2022; 41(3):471-489.

PMID: 35908000 DOI: 10.1007/s10555-022-10054-2.


References
1.
Cold S, Hansen S, Overvad K, Rose C . A woman's build and the risk of breast cancer. Eur J Cancer. 1998; 34(8):1163-74. DOI: 10.1016/s0959-8049(97)10167-8. View

2.
Ziegler R . Anthropometry and breast cancer. J Nutr. 1997; 127(5 Suppl):924S-928S. DOI: 10.1093/jn/127.5.924S. View

3.
Forsen T, Eriksson J, Tuomilehto J, Osmond C, Barker D . Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ. 1999; 319(7222):1403-7. PMC: 28284. DOI: 10.1136/bmj.319.7222.1403. View

4.
Cerhan J, Kushi L, Olson J, Rich S, Zheng W, Folsom A . Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst. 2000; 92(3):261-5. DOI: 10.1093/jnci/92.3.261. View

5.
Nagasawa H, Yanai R, Shodono M, Nakamura T, Tanabe Y . Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats. Cancer Res. 1974; 34(10):2643-6. View